HMOX1 and epilepsy: Consequently, targeting the Nrf2/HO‐1 signaling pathway is emerging as a compelling strategy for developing novel therapeutic interventions aimed at safeguarding the brain from the harmful consequences of epilepsy and related neurodegenerative disorders.